kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Migalo Holdings
5535
Rentracks
6045
JP Stock MarketDetailed Quotes
6914 Optex Group
- 1660
- +26+1.59%
20min DelayTrading Feb 18 10:04 JST
62.64BMarket Cap10.46P/E (Static)
1663High1617Low64.70KVolume1634Open1634Pre Close105.95MTurnover202052wk High0.21%Turnover Ratio37.74MShares132752wk Low158.68EPS TTM51.23BFloat Cap3640Historical High10.46P/E (Static)30.86MShs Float183Historical Low158.68EPS LYR2.82%Amplitude40.00Dividend TTM1.18P/B100Lot Size2.41%Div YieldTTM
Optex Group Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 12.23%63.27B | 12.56%15.06B | 11.88%15.46B | 2.85%56.37B | 6.92%15.34B | 4.63%13.84B | 0.26%13.38B | -0.57%13.82B | 19.50%54.81B | 21.38%14.34B |
| Cost of revenue | 13.79%31.4B | 13.39%7.57B | 18.16%7.79B | 2.93%27.6B | 3.39%7.48B | 9.27%6.85B | 3.07%6.68B | -3.50%6.59B | 21.97%26.81B | 25.26%7.24B |
| Gross profit | 10.75%31.87B | 11.75%7.48B | 6.14%7.67B | 2.77%28.78B | 10.51%7.86B | 0.46%6.99B | -2.39%6.7B | 2.26%7.23B | 17.23%28B | 17.70%7.11B |
| Operating expense | 8.17%24.74B | 5.35%6.1B | 8.05%5.92B | 5.44%22.87B | -2.02%5.97B | 7.19%5.63B | 7.38%5.79B | 10.67%5.48B | 12.69%21.69B | 16.76%6.1B |
| Staff costs | 8.76%10.15B | ---- | ---- | 6.22%9.33B | ---- | ---- | ---- | ---- | 11.49%8.78B | ---- |
| Research and development costs | 9.22%3.7B | ---- | ---- | 0.09%3.39B | ---- | ---- | ---- | ---- | 8.99%3.38B | ---- |
| Other operating expenses | 7.27%10.9B | ---- | ---- | 6.63%10.16B | ---- | ---- | ---- | ---- | 15.21%9.53B | ---- |
| Operating profit | 20.74%7.13B | 52.53%1.39B | 0.17%1.76B | -6.44%5.9B | 86.05%1.88B | -20.28%1.36B | -38.23%908M | -17.36%1.75B | 36.13%6.31B | 23.75%1.01B |
| Net non-operating interest income (expenses) | -7.69%36M | -7.69%12M | 166.67%8M | 244.44%39M | 350.00%15M | 233.33%8M | 244.44%13M | 150.00%3M | -42.11%-27M | -20.00%-6M |
| Non-operating interest income | 0.00%104M | 3.45%30M | 33.33%24M | 271.43%104M | 230.00%33M | 242.86%24M | 383.33%29M | 260.00%18M | 100.00%28M | 150.00%10M |
| Non-operating interest expense | 4.62%68M | 12.50%18M | 6.67%16M | 18.18%65M | 12.50%18M | 23.08%16M | 6.67%16M | 36.36%15M | 66.67%55M | 77.78%16M |
| Net investment income | 425M | 11.56%222M | 358.23%204M | -68.78%64M | -43.47%199M | -135.43%-79M | 131.38%553M | -391.03%-227M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -252.63%-87M | 100.00%30M | -957.69%-223M | 209.62%57M | 75.32%-19M | 400.00%35M | 15M | 44.44%26M | 75.93%-52M | 62.80%-77M |
| Income from associates and other participating interests | -92.11%3M | -130.77%-4M | -111.76%-2M | -41.54%38M | 0 | -55.56%8M | -31.58%13M | 6.25%17M | 140.74%65M | -25.00%12M |
| Special income (charges) | -99.12%3M | -900.00%-10M | -87.50%1M | 199.13%342M | 101.02%4M | 33,000.00%331M | -107.14%-1M | -76.47%8M | -298.28%-345M | -325.14%-394M |
| Less:Other special charges | 76.92%-3M | 900.00%10M | 87.50%-1M | 75.47%-13M | 0.00%-4M | -100.00%-2M | 107.14%1M | 76.47%-8M | -2,750.00%-53M | -500.00%-4M |
| Less:Write off | --0 | ---- | ---- | -182.66%-329M | --0 | ---- | ---- | ---- | --398M | --398M |
| Other non-operating income (expenses) | -60.09%87M | -25.93%20M | -50.00%15M | 190.67%218M | 600.00%112M | 276.92%49M | 50.00%27M | 7.14%30M | -61.73%75M | -55.56%16M |
| Income before tax | 15.04%7.59B | 40.58%1.66B | 0.11%1.76B | 0.32%6.6B | 445.18%1.81B | -4.68%1.85B | -36.84%1.18B | -27.89%1.76B | 30.69%6.58B | -63.36%332M |
| Income tax | -4.58%1.89B | 13.87%427M | -20.24%457M | 9.01%1.99B | 500.00%600M | -19.37%437M | -23.31%375M | -16.96%573M | 43.95%1.82B | 7.53%100M |
| Net income | 23.51%5.69B | 53.12%1.23B | 9.97%1.3B | -3.01%4.61B | 421.12%1.21B | 1.14%1.42B | -41.76%802M | -32.17%1.18B | 26.21%4.75B | -71.46%232M |
| Net income continuous operations | 23.49%5.69B | 53.05%1.23B | 9.97%1.3B | -3.01%4.61B | 421.55%1.21B | 1.00%1.42B | -41.64%803M | -32.21%1.18B | 26.23%4.75B | -71.46%232M |
| Noncontrolling interests | 300.00%4M | 0 | 0 | 1M | 1M | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 23.46%5.69B | 52.80%1.23B | 10.07%1.3B | -3.03%4.61B | 420.69%1.21B | 1.07%1.42B | -41.68%803M | -32.19%1.18B | 26.32%4.75B | -71.36%232M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 23.46%5.69B | 52.80%1.23B | 10.07%1.3B | -3.03%4.61B | 420.69%1.21B | 1.07%1.42B | -41.68%803M | -32.19%1.18B | 26.32%4.75B | -71.36%232M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 23.23%159.86 | 52.50%34.45 | 10.09%36.65 | -3.03%129.73 | 420.67%34 | 1.12%39.85 | -41.75%22.59 | -32.16%33.29 | 28.42%133.79 | -71.02%6.53 |
| Diluted earnings per share | 23.31%158.68 | 52.79%34.21 | 9.95%36.34 | -3.15%128.68 | 422.48%33.7 | 1.07%39.54 | -41.86%22.39 | -32.25%33.05 | 28.24%132.86 | -71.19%6.45 |
| Dividend per share | 0.00%40 | 0.00%20 | 0 | 11.11%40 | 11.11%20 | 0 | 11.11%20 | 0 | 20.00%36 | 20.00%18 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |